DE69418931D1 - Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten - Google Patents

Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten

Info

Publication number
DE69418931D1
DE69418931D1 DE69418931T DE69418931T DE69418931D1 DE 69418931 D1 DE69418931 D1 DE 69418931D1 DE 69418931 T DE69418931 T DE 69418931T DE 69418931 T DE69418931 T DE 69418931T DE 69418931 D1 DE69418931 D1 DE 69418931D1
Authority
DE
Germany
Prior art keywords
vip
analogs
fragments
treatment
neurodegenerative diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69418931T
Other languages
English (en)
Other versions
DE69418931T2 (de
Inventor
Illana Gozes
Matityahu Fridkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd, Yeda Research and Development Co Ltd filed Critical Ramot at Tel Aviv University Ltd
Application granted granted Critical
Publication of DE69418931D1 publication Critical patent/DE69418931D1/de
Publication of DE69418931T2 publication Critical patent/DE69418931T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69418931T 1993-03-16 1994-03-08 Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten Expired - Fee Related DE69418931T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10506193A IL105061A (en) 1993-03-16 1993-03-16 Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof

Publications (2)

Publication Number Publication Date
DE69418931D1 true DE69418931D1 (de) 1999-07-15
DE69418931T2 DE69418931T2 (de) 2000-03-16

Family

ID=11064619

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69418931T Expired - Fee Related DE69418931T2 (de) 1993-03-16 1994-03-08 Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten

Country Status (7)

Country Link
EP (1) EP0620008B1 (de)
JP (1) JPH0769919A (de)
KR (1) KR100305453B1 (de)
CN (1) CN1140294C (de)
DE (1) DE69418931T2 (de)
IL (1) IL105061A (de)
TW (1) TW290458B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118003A0 (en) * 1996-04-23 1996-08-04 Yeda Res & Dev Novel vip fragments and pharmaceutical compositions comprising them
FR2775902B1 (fr) * 1998-03-13 2001-05-11 Assist Publ Hopitaux De Paris Utilisation d'analogues du vip dans la prevention et le traitement des lesions cerebrales du nouveau-ne humain
US6713445B1 (en) * 1998-04-06 2004-03-30 Advanced Immuni T, Inc. Peptides for treatment of HIV infection
US20020115605A1 (en) * 2000-08-24 2002-08-22 Matthew During Novel peptide with effects on cerebral health
WO2002043746A2 (en) 2000-11-28 2002-06-06 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
CN1313149C (zh) * 2002-06-10 2007-05-02 蒙杜生物科技安斯塔特实验室 具有血管活性肠肽的生物学活性的化合物在治疗结节病中的用途
EP2010223A2 (de) * 2006-04-07 2009-01-07 The Board Of Trustees Of The University Of Illinois Hydrophile polymerkonjugierte lipide für peptid- und proteinfaltungsstörungen
KR101242066B1 (ko) 2010-05-19 2013-03-12 강원대학교산학협력단 Ｖｉｐ를 유효성분으로 함유하는 기분장애 예방 및 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2098922A1 (en) * 1990-12-21 1992-06-22 Mahrendra S. Rao Neuronal cholinergic differentiation factor
IL99924A (en) * 1991-10-31 1995-12-31 Yeda Res & Dev Derivatives of structurally modified vip and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69418931T2 (de) 2000-03-16
EP0620008A1 (de) 1994-10-19
IL105061A0 (en) 1993-07-08
CN1100327A (zh) 1995-03-22
KR940021074A (ko) 1994-10-17
CN1140294C (zh) 2004-03-03
JPH0769919A (ja) 1995-03-14
EP0620008B1 (de) 1999-06-09
IL105061A (en) 2000-11-21
TW290458B (de) 1996-11-11
KR100305453B1 (ko) 2001-11-22

Similar Documents

Publication Publication Date Title
DE69836752D1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69412552T2 (de) Medizinisches Instrument zur Behandlung von Sinusitis
ATE331522T1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
ATE255888T1 (de) Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE69432299T2 (de) Multiple Botulinum Toxine zur Behandlung von neuromuskulären Störungen und Zuständen
DE69124293D1 (de) Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
FI972433A0 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoon soveltuvia koostumuksia
DE69212620T2 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
DE69527749D1 (de) Kugelförmige Aktivkohle zur Behandlung von Bauchentzündungen
DE69734296D1 (de) Neue dikaffeoylchinasäurederivate und deren verwendung zur behandlung von hepatitis b
DE69914951D1 (de) Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE69625883D1 (de) Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE59511032D1 (de) Verwendung von notoginsenosid r1 zur behandlung von endotoxinschock oder herzerkrankungen
DE3686019T2 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE3586420D1 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee